Drug intelligence / Profile preview

polymyxin b sulfate + hydrocortisone + neomycin

Development stage
Approved
Lead developer
Sandoz
Modality
Small Molecules
Administration
Ophthalmic, Otic, Topical
01

Overview

**Polymyxin b sulfate + hydrocortisone + neomycin** is a fixed-dose topical anti-infective and anti-inflammatory combination drug used in ophthalmic and otic formulations for bacterial eye and ear conditions. Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding the 30S ribosomal subunit, polymyxin B is a polypeptide antibiotic that disrupts the outer membrane of susceptible Gram-negative bacteria through binding to lipopolysaccharide and membrane phospholipids, and hydrocortisone is a glucocorticoid receptor agonist that suppresses local inflammatory responses, reducing edema, erythema, and discomfort. The product is marketed under multiple prescription brand names including Cortisporin and Casporyn HC, with manufacturers including Sandoz and Casper Pharma, and is approved for steroid-responsive inflammatory ocular conditions where bacterial infection or risk of infection exists as well as superficial bacterial infections of the external auditory canal and certain mastoidectomy or fenestration cavity infections.

Brand names
CortisporinAK-Spore HCOtosporinCasporyn HCPediotic
Other names
neomycin + polymyxin b sulfate + hydrocortisoneneomycin and polymyxin b sulfates and hydrocortisoneneomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspensionneomycin and polymyxin b sulfates and hydrocortisone otic solution
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)Lipopolysaccharide lipid A / outer membrane phospholipids

Beyond the preview

Go deeper on polymyxin b sulfate + hydrocortisone + neomycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymyxin b sulfate + hydrocortisone + neomycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call